P. Bravetti

Paul Bravetti (Chief Operating Officer, PharmD, HEC Paris) is specialized in medical oncology and brings a wealth of experience from his international career at Roche, Servier, and Takeda Oncology, leading teams in Medical, Marketing, and Commercial functions.

Paul has previously managed successful product launches in immuno-oncology including melanoma, lung cancer and bio-molecular diagnosis across EU and Asia.